Nos publications

Notre équipe a publié de nombreux articles scientifiques dans des revues internationales.

Cancer du sein

From prospective clinical trial to reducing social inequalities in health: The DESSEIN trial, concept and design of a multidisciplinary study in precarious patients with breast cancer. Ngô C, Dinut A, Bochaton A, Charreire H, Desprès C, Baffert S, Lécuru F, Chatellier G. BMC Public Health. 2019 Nov 4;19(1):1450. 


Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data. Abécassis J, Hamy AS, Laurent C, Sadacca B, Bonsang-Kitzis H, Reyal F, Vert JP.PLoS One. 2019 Nov 7;14(11).  


Associations between persistent organic pollutants and risk of breast cancer metastasis. Koual M, Cano-Sancho G, Bats AS, Tomkiewicz C, Kaddouch-Amar Y, Douay-Hauser N, Ngo C, Bonsang H, Deloménie M, Lecuru F, Le Bizec B, Marchand P, Botton J, Barouki R, Antignac JP, Coumoul X. Environ Int. 2019 Nov;132:105028.


Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Hamy AS, Bonsang-Kitzis H, De Croze D, Laas E, Darrigues L, Topciu L, Menet E, Vincent-Salomon A, Lerebours F, Pierga JY, Brain E, Feron JG, Benchimol G, Lam GT, Laé M, Reyal F.Clin Cancer Res. 2019 Nov 15;25(22):6731-6741.


Using the Recommendations Inferred by a Decision Support System to Compare Breast Cancer Clinical Practice Guidelines. Seroussi B, Prebet C, Ngo C, Teixeira L, Guézennec G, Bouaud J.Stud Health Technol Inform. 2019;258:60-64.


Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF, Rouzier R, Faure C, Paillocher N, Chauvet MP, Houvenaeghel G, Gutowski M, De Blay P, Verhaeghe JL, Barranger E, Lefebvre C, Ngo C, Ferron G, Palpacuer C, Campion L. Breast Cancer Res Treat. 2018 Oct 20. 


Robotic-assisted latissimus dorsi muscle harvest for immediate breast reconstruction.

Pacelli J, Sharifzadehgan S, Rua S, Houvenaeghel G, Ngo C, Bats AS, Lécuru F, Delomenie M. Gynecol Obstet Fertil Senol. 2018 Sep 28.


Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.Hamy AS, Lam GT, Laas E, Darrigues L, Balezeau T, Guerin J, Livartowski A, Sadacca B, Pierga JY, Vincent-Salomon A, Coussy F, Becette V, Bonsang-Kitzis H, Rouzier R, Feron JG, Benchimol G, Laé M, Reyal F.Breast Cancer Res Treat. 2018 Jun;169(2):295-304.


What about sentinel lymph node biopsy for early breast cancer during pregnancy? Balaya V, Bonsang-Kitzis H, Ngo C, Delomenie M, Gosset M, Mimouni M, Nos C, David PM, Bats AS, Lecuru F.  J Gynecol Obstet Hum Reprod. 2018 Mar 3.


Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort. Hamy AS, Belin L, Bonsang-Kitzis H, Paquet C, Pierga JY, Lerebours F, Cottu P, Rouzier R, Savignoni A, Lae M, Reyal F.Br J Cancer. 2018 Mar 20;118(6):e14.


Personality and breast cancer screening in women of the GAZEL cohort study. Lemogne C, Turinici M, Panjo H, Ngo C, Canoui-Poitrine F, Chauvet-Gelinier JC, Limosin F, Consoli SM, Goldberg M, Zins M, Ringa V.  Cancer Med. 2018 Feb;7(2):515-524.


Atypical Distant Metastasis of Breast Malignant Phyllodes Tumors: A Case Report and Literature Review. de Foucher T, Roussel H, Hivelin M, Rossi L, Cornou C, Bats AS, Deloménie M, Lécuru F, Ngô C.  Case Rep Obstet Gynecol. 2017; 2017:8963013.


New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels. Sadacca B, Hamy AS, Laurent C, Gestraud P, Bonsang-Kitzis H, Pinheiro A, Abecassis J, Neuvial P, Reyal F.Sci Rep. 2017 Nov 9;7(1):15126.


Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer. Hamy AS, Pierga JY, Sabaila A, Laas E, Bonsang-Kitzis H, Laurent C, Vincent-Salomon A, Cottu P, Lerebours F, Rouzier R, Lae M, Reyal F.Ann Oncol. 2017 Sep 1;28(9):2233-2240.


Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers. Bonsang-Kitzis H, Mouttet-Boizat D, Guillot E, Feron JG, Fourchotte V, Alran S, Pierga JY, Cottu P, Lerebours F, Stevens D, Vincent-Salomon A, Sigal-Zafrani B, Campana F, Rouzier R, Reyal F.PLoS One. 2017 Feb 27;12(2):e0169962.


Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection. Nos C, Clough KB, Bonnier P, Lasry S, Le Bouedec G, Flipo B, Classe JM, Missana MC, Doridot V, Giard S, Charitansky H, Charles-Nelson A, Bats AS, Ngo CEur J Surg Oncol. 2016 Dec; 42(12):1827-1833.


A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways. Hamy AS, Bonsang-Kitzis H, Lae M, Moarii M, Sadacca B, Pinheiro A, Galliot M, Abecassis J, Laurent C, Reyal F. PLoS One. 2016 Dec 22;11(12):e0167397.


Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study. Renaudeau C, Lefebvre-Lacoeuille C, Campion L, Dravet F, Descamps P, Ferron G, Houvenaeghel G, Giard S, Tunon de Lara C, Dupré PF, Fritel X, Ngô C, Verhaeghe JL, Faure C, Mezzadri M, Damey C, Classe JM. Breast. 2016 Aug; 28:54-9


Ganglion sentinelle et curage axillaire dans le cancer du sein : la pratique française face aux recommandations à l'ère post Z011. A Clavier, C Cornou, P Capmas, AS Bats, CBensaid, C Nos, FLécuru, CNgô. J Gynecol Obstet Biol Reprod (Paris). 2016 May; 45(5):451-8.


p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer. Lodillinsky C, Infante E, Guichard A, Chaligné R, Fuhrmann L, Cyrta J, Irondelle M, Lagoutte E, Vacher S, Bonsang-Kitzis H, Glukhova M, Reyal F, Bièche I, Vincent-Salomon A, Chavrier P.Oncogene. 2016 Jan 21;35(3):344-57.


Pathologic complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort. Hamy AS, Belin L, Bonsang-Kitzis H, Paquet C, Pierga JY, Lerebours F, Cottu P, Rouzier R, Savignoni A, Lae M, Reyal F. Br J Cancer. 2016 Jan 12;114(1):44-52.


Breast pain: Recommendations. Ngô CSeror JChabbert-Buffet N. J GynecolObstetBiolReprod (Paris). 2015 Dec; 44(10):938-46.


Management of breast nipple discharge:Recommendations.Ouldame r LKellal ILegendre GNgô CChopier JBody G. J GynecolObstetBiolReprod (Paris). 2015 Dec;44(10):927-37.


Network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis. Bonsang-Kitzis H, Sadacca B, Hamy-Petit AS, Moarii M, Pinheiro A, Laurent C, Reyal F. Oncoimmunology. 2015 Jun 24;5(1):e1061176.


Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X, Laé M, Pierga JY, Reyal F. PLoS One. 2015 Dec 18;10(12):e0144359.


Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy. Héquet D, Zarca K, Dolbeault S, Couturaud B, Ngô C, Fourchotte V, De La Rochefordière A, Féron JG, Fitoussi A, Bélichard C, Reyal F, Laki F, Hajage D, Sigal B, Asselain B, Alran S; Institut Curie Breast Cancer Group, Roman Rouzier.  Springerplus. 2013 Jul 18;2:325.


Time dependent prognostic impact of circulating tumor cells detection in non-metastatic breast cancer: 70 months analysis of the REMAGUS02 study. FC. Bidard, L. Belin, S. Delaloge, F. Lerebours, C. Ngo, F. Reyal, S. Alran, S. Giacchetti, M. Marty, R. Lebofsky and JY. Pierga. International Journal of Breast Cancer, 2013, 2013:130470.


Prediction of axillary lymph node status in male breast carcinoma.Vaysse C, Sroussi J, Mallon P, Feron JG, Rivain AL, Ngo C, Belichard C, Lasry S, Pierga JY, Couturaud B, Fitoussi A, Laki F, Fourchotte V, Alran S, Kirova Y, Vincent-Salomon A, Sastre-Garau X, Sigal-Zafrani B, Rouzier R, Reyal F. Ann Oncol 2013 Feb; 24(2): 370-6.


Validation over time of a nomogram including Her2 status to predict the sentinel node positivity in early breast cancer.C.Ngô, D. Mouttet, Y. De Rycke, F. Reyal, V. Fourchotte, F. Hugonnet, MC Falcou, FC. Bidard, A. Vincent-Salomon, A. Fourquet, S. Alran. Eur J Surg Oncol 2012 Dec;38(12):1211-7.


Intraoperative ultrasound localization of non-palpable breast cancers C Ngô, AG  Pollet , J Laperrelle , G Ackerman, S Gomme, F Thibault, V Fourchotte, RJ Salmon.. Ann Surg Oncol, 2007, Sep;14(9):2485-9.

Cancer du col de l'utérus

Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer. Balaya V, Bresset A, Guani B, Magaud L, Montero Macias R, Delomenie M, Bonsang-Kitzis H, Ngô C, Bats AS, Mathevet P, Lécuru F.Gynecol Oncol. 2020 Jan;156(1):93-99.


Sentinel lymph node biopsy in early-stage cervical cancer: current state of art. Balaya V, Guani B, Bonsang-Kitzis H, Deloménie M, Ngô C, Montero Macias R, Koual M, Nguyen-Xuan HT, Bats AS, Mathevet P, Lécuru F. Bull Cancer. 2019 Oct 15.

The clinical implication of lymph nodes micrometastases and isolated tumor cells in patients with cervical cancer: A systematic review. Delomenie M, Bonsang-Kitzis H, Bats AS, Ngo C, Balaya V, Xuan HTN, Koual M, Mathevet P, Lecuru F. Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:71-76.


Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer. Balaya V, Mathevet P, Magaud L, Bonsang-Kitzis H, Delomenie M, Montero Macias R, Ngô C, Bats AS, Lécuru F. Gynecol Oncol. 2019 Jul;154(1):102-109.


Predictive factors of severe perioperative morbidity of radical hysterectomy with lymphadenectomy in early-stage cervical cancer: A French prospective multicentric cohort of 248 patients. Balaya V, Mathevet P, Magaud L, Delomenie M, Bonsang-Kitzis H, Ngô C, Huchon C, Bats AS, Lecuru F. Eur J Surg Oncol. 2019 Apr;45(4):650-658.


Precaval positive sentinel lymph node with bilateral negative pelvic sentinel lymph node in low-risk endometrial cancer patient. Montero Macias R, Balaya V, Bonsang-Kitzis H, Deloménie M, Gosset M, Mimouni M, Simon V, Lecurieux-Lafayette C, Larouzee E, Ngô C, Bats A, Lécuru F. J Gynecol Obstet Hum Reprod. 2019 Dec;48(10):887-889.


Three-Dimensional Modelization of the Female Human Inferior Hypogastric Plexus: Implications for Nerve-Sparing Radical Hysterectomy. Balaya V, Guimiot F, Uhl JF, Ngo C, Delomenie M, Bonsang-Kitzis H, Gosset M, Mimouni M, Bats AS, Delmas V, Douard R, Lécuru F. Gynecol Obstet Invest. 2019;84(2):196-203.


Evidence for the use of robotically assisted surgery in gynecologic cancers. Ngô C, Cornou C, Rossi L, Bats AS, Bensaid C, Frati A, Nos C, Lécuru F. Curr Opin Oncol. 2016 Sep;28(5):398-403.


Anatomical consideration for the technique of nerve-sparing during radical hysterectomy for cervical cancer. Balaya V, Ngo C, Rossi L, Cornou C, Bensaid C, Douard R, Bats AS, Lecuru F. . Gynecol Obstet Fertil. 2016 Sep;44(9):517-25.


From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer. Ngo C, Samuels S, Bagrintseva K, Slocker A, Hupé P, Kenter G, Popovic M, Samet N, Tresca P, von der Leyen H, Deutsch E, Rouzier R, Belin L, Kamal M, Scholl S; RAIDs consortium http://www.raids-fp7.eu/. BMC Cancer. 2015 Nov 4; 15:842


Robot-Assisted Laparoscopic Partial Colpectomy and IntracorporealIleal Conduit Urinary Diversion (Bricker) for Cervical Adenocarcinoma Recurrence. Uzan JCornou CBensaid CAudenet FNgô CBats ASLecuru F..Case Rep ObstetGynecol.2015;2015:241094.

Risk of port-site metastases in pelvic cancers after robotic surgery. Seror J, Bats AS, Bensaïd C, Douay-Hauser N, Ngo C, Lécuru F. Eur J SurgOncol. 2015 Jan 16.


Long term outcome and quality of life after pelvic exenteration for recurrent endometrial and cervical cancers. C. Ngô, C. Abboud, P. Meria, V. Fourchotte, P. Mariani, B. Baranger, X. Sastre, C. Malhaire, AC Philippe, A. de la Rochefordière, and S. Alran. Open J Obstet Gynecol 2013, vol 3.


Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: a ten years follow up of 257 patients treated at a single institution. C. Ngô, S. Alran, C. Plancher, V. Fourchotte, P. Petrow,  M. Campitelli, S. Batwa, X. Sastre, RJ. Salmon, A. de la Rochefordière. Gynecol Oncol 2011, Nov;123(2):248-52.

Cancer ovarien

Prognostic impact of initial tumor load and intraperitoneal disease dissemination patterns in patients with advanced ovarian cancer undergoing complete cytoreductive surgery. Uzan J, Bonsang-Kitzis H, Rossi L, Rance B, Bats AS, Gosset M, Deloménie M, Pujade-Lauraine E, Lécuru F, Ngô C. Eur J Surg Oncol. 2019 Sep;45(9):1619-1624.


Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis. Fournier M, Huchon C, Ngo C, Bensaid C, Bats AS, Combe P, le FrèreBelda MA, Fournier L, Berger A, Lecuru F.  Eur J Surg Oncol. 2018 Jan 13.  


A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer. Chesnais M, Lecuru F, Mimouni M, Ngo C, Fauconnier A, Huchon C.  PLoS One. 2017 Nov 8;12(11):e0187245.


Is complete cytoreductive surgery feasible in this patient with ovarian cancer?Dessapt AL, Huchon C, Ngo C, Bats AS, Bensaid C, Lecuru F. Surg Oncol. 2016 Sep;25(3):326-31.


Surgical complexity impact on survival after complete cytoreductive surgery for advanced ovarian cancer. Martinez A, Ngô C, Leblanc E, Morice P, Luyckx M, Darai E, Classe JM, Guyon F, Pomel C, Ferron G, Filleron T, Querleu D. Ann Surg Oncol. 2016 Aug; 23(8):2515-21.


Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration. Bougherara HMansuet-Lupo AAlifano MNgô CDamotte DLe Frère-Belda MADonnadieu EPeranzoni E. Front Immunol. 2015 Oct 12;6:500.


La chirurgie des cancers de l'ovaire : les grands principes encore valides. F. Lécuru, AS. Bats, C. Bensaid, C. Ngô, N. Douay-Hauser, J. Seror, C. Nos, P. Combe, J. Medioni, E. Pujade-Lauraine. Oncologie (2014) 16 : 313-316.

Cancer de l'endomètre

Endometrial cancer in the elderly: does age influence surgical treatments, outcomes, and prognosis?Koual M, Ngo C, Girault A, Lécuru F, Bats AS. Menopause. 2018 Sep; 25(9):968-976.


Assessment of different pre and intra-operative strategies to predict the actual ESMO risk group and to establish the appropriate indication of lymphadenectomy in endometrial cancer. Vieillefosse S, Huchon C, Chamming's F, Le Frère-Belda MA, Fournier L, Ngô C, Lécuru F, Bats AS. J Gynecol Obstet Hum Reprod. 2018 Aug 28.


Dual docking robotic surgical staging for high risk endometrial cancer. Loaec C, Bats AS, Ngo C, Cornou C, Rossi L, Bensaid C, Nos C, Lecuru F. . Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:79-83.


Lynch syndrome and endometrial cancer. Bats AS, Rossi L, Le Frere-Belda MA, Narjoz C, Cournou C, Gosset M, Ngo C, Delomenie M, Nos C, Blons H, Laurent-Puig P, Lecuru F.  Bull Cancer. 2017 Dec; 104(12):1013-1021.


Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without Tamoxifen: a comparative study in 363 patients. C. Ngô, C. Brugier, C. Plancher, A. de la Rochefordière, S. Alran, JG. Féron, C. Malhaire, S.Scholl, X. Sastre, R. Rouzier and V.Fourchotte. EJSO, 2014 jun 3.

Endométriose

The mTOR/Akt inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. M. Leconte, C. Nicco, C. Ngô, C. Chéreau, J. Guibourdenche, S. Arkwright, B. Weill, C. Chapron, B. Dousset,  and F. Batteux Am J Pathol. 2011 Aug;179(2):880-9.


Questioning concerning adolescent patients’ history contains markers associated with deep infiltrating endometriosis. C. Chapron, MC. Lafay-Pillet, E. Monceau, B. Borghese, C. Ngô, C.Souza, D. de Ziegler. Fertil Steril 2011, Mar 1;95(3):877-87.


Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. Ngô C, Nicco C, Leconte M, Chéreau C, S. Arkwright, MC. Vacher-Lavenu, Weill B, Chapron C, Batteux F. Journal of Pathology 2010, 222:148-57.


Smoking habits in 411 women with histologically proven endometriosis and 567 unaffected controls. C. Chapron, C. Souza, D. de Ziegler, MC. Lafay-Pillet, C. Ngô, G. Bijaoui, F. Goffinet, B. Borghese. Fertil Steril 2010, Nov;94(6):2353-5.


Antiproliferative effect of cannabinoid agonists on deep infiltrating endometriosis. M. Leconte, C. Nicco, C. Ngô, S. Arkwright, C. Chéreau,  J. Guibourdenche, B. Weill,  C. Chapron, B. Dousset, and Frédéric Batteux. American Journal of Pathology 2010 Dec;177(6):2963-70.


Antiproliferative effects of Anastrozole, Methotrexate and 5-fluorouracil on endometriosis in vitro and in vivo. Ngô C, Nicco C, Leconte M, Chéreau C, Weill B, Batteux F, Chapron C. Fertil Steril 2009, Dec 31.


Reactive oxygene species control endometriosis progression. Ngô C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Am J Pathol 2009; 175 :225-234.